SUPRATENTORIAL GLIOBLASTOMA
Clinical trials for SUPRATENTORIAL GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new SUPRATENTORIAL GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for SUPRATENTORIAL GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cancer gene therapy trial pulled before starting
Disease control TerminatedThis trial aimed to test whether adding a gene therapy (Toca 511) and a special pill (Toca FC) to standard radiation and chemotherapy could help people with a newly diagnosed aggressive brain cancer called glioblastoma. The treatment was designed to turn cancer cells into drug fa…
Matched conditions: SUPRATENTORIAL GLIOBLASTOMA
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 06:51 UTC
-
Immunotherapy boosts standard treatment for aggressive brain cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation can help people with newly diagnosed glioblastoma, a fast-growing brain cancer. About 52 adults will receive the combination therapy to see if it improves survival and cont…
Matched conditions: SUPRATENTORIAL GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC